Glucose level and myocardial recovery after warm arrest

Annals of Thoracic Surgery

Volumn 62, Issue 6, 1996, Pages 1825-1829

  Ning, Xue Han ^a   Childs, Keith F ^a   Bolling, Steven F ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; HEART ARREST; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION;

ADENINE NUCLEOTIDES; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENERGY METABOLISM; FEMALE; GLUCOSE; HEART ARREST, INDUCED; HYDROGEN-ION CONCENTRATION; LACTIC ACID; MALE; MYOCARDIUM; NUCLEOTIDES; OXYGEN CONSUMPTION; PHOSPHATES; RABBITS; TEMPERATURE;

EID: 0030559688     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)00887-9     Document Type: Article

References (25)

1. 1. Salerno TA, Houck JP, Barrozo CAM, et al. Retrograde continuous warm blood cardioplegia: a new concept in myocardial protection. Ann Thorac Surg 1991;51:1023-5.
2. 2. Lichtenstein SV, Ashe KA, El Dalati H, Cusimano RJ, Panos A, Slutsky AS. Warm heart surgery. J Thorac Cardiovasc Surg 1991;101:269-74.
3. 3. Christakis GT, Koch JP, Deemar KA, et al. A randomized study of the systemic effects of warm heart surgery. Ann Thorac Surg 1992;54:449-59.
4. 4. Mallet RT, Hartman SA, Bunger R. Glucose requirement for postischemic recovery of perfused working heart. Eur J Biochem 1990;188:481-93.
5. 5. Bolling SF, Childs KF, Ning X-H. Amino acid substrate preloading and postischemic myocardial recovery. J Surg Res 1992;53:342-8.
6. 6. Doherty NE III, Turocy JF, Geffin GA, O'Keefe DD, Titus JS, Daggett WM. Benefits of glucose and oxygen in multidose cold cardioplegia. J Thorac Cardiovasc Surg 1992;103:219-29.
7. 7. Guilbeau EJ, Moore LK, Viole AJ, et al. Effect of intermittent infusions of glucose-containing crystalloid cardioplegic solution on myocardial tissue lactic acid and recovery of contractility. J Thorac Cardiovasc Surg 1984;87:920-9.
8. 8. Von Oppell UO, Du Toit EF, King LM, et al. Beneficial effect of glucose and multidose reinfusions of cardioplegic solution. J Thorac Cardiovasc Surg 1991;102:405-12.
9. 9. Steinberg JB, Doherty NE, Munfakh NA, et al. Oxygenated cardioplegia: the metabolic and functional effects of glucose and insulin. Ann Thorac Surg 1991;51:620-9.
10. 10. Lazar HL. Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions. J Card Surg 1994;9:474-8.
11. 11. Akagawa HT, Tajiri Y, Hoshino M, et al. Questionable role of glucose-insulin in cardioplegic solution. J Cardiovasc Surg 1983;24:215-21.
12. 12. Hearse DL, Stewart DA, Braimbridge MV. Myocardial protection during ischemic cardiac arrest: Possible deleterious effects of glucose and mannitol in coronary infusates. J Thorac Cardiovasc Surg 1978;76:16-23.
13. 13. Conti VR, Lao RL. Metabolic and junctional effects of carbohydrate substrate with single-dose and multiple-dose potassium cardioplegia. Ann Thorac Surg 1983;36:320-7.
14. 14. Brian D, Wisneski JA, Neese RA, et al. Myocardial lactate release during ischemia in swine, relation to regional blood flow. Circulation 1990;81:1948-58.
15. 15. Neely JR, Grotyohan LW. Role of glycolytic products in damage to ischemic myocardium. Circ Res 1984;55:816-24.
16. 16. Ning X-H, Ding X, Childs KF, Bolling SF. Lactate is not a critical factor in postischemic reperfusion injury in isolated rabbit hearts. FASEB J 1993;7:A120.
17. 17. Martin TD, Graver JM, Gott JP, et al. Prospective, randomized trial of retrograde warm blood cardioplegia: myocardial benefit and neurologic threat. Ann Thorac Surg 1994;57:298-304.
18. 18. Holzman IR, Griepp RB. Metabolic correlates of neurologic and behavioral injury after prolonged hypothermic circulatory arrest. J Thorac Cardiovasc Surg 1995;109:959-75.
19. 19. Van Camp JR, Brunsting LA, Childs KF, Bolling SF. Functional recovery after ischemia: warm versus cold cardioplegia. Ann Thorac Surg 1995;59:795-803.
20. 20. Fremes SE, Furukawa RD, Li RK, Tumiati LC, Weisel RD, Mickle DA. In vitro assessment of the effects of glucose added to the University of Wisconsin solution on myocyte preservation. Circulation 1992;86(Suppl 2):289-94.
21. 21. Orita H, Fukasawa M, Hirooka S, Minowa T, Uchino H, Washio M. Prevention of postischemic reperfusion injury: the improvement of myocardial tissue blood flow after ischemia by terminal nicorandil-Mg cardioplegia. Surg Today 1993;23:344-9.
22. 22. Kao RL, Magovern GJ. Prevention of reperfusional damage from ischemic myocardium. J Thorac Cardiovasc Surg 1986; 91:106-14.
23. 23. Owen P, du Toit EF, Opie LH. The optimal glucose concentration for intermittent cardioplegia in isolated rat heart when added to St. Thomas' Hospital cardioplegic solution. J Thorac Cardiovasc Surg 1993;105:995-1006.
24. 24. Yang SS, Hearse DJ. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution. Can J Cardiol 1989;5:401-7.
25. 25. Brodin LA, Dahlgren G, Ekestrom S, Settergren G, Ohqvist G. Influence of glucose-insulin-potassium on left ventricular function during coronary artery bypass grafting. Scand J Thorac Cardiovasc Surg 1993;27:27-34.